980 related articles for article (PubMed ID: 33163337)
21. Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease.
Zhou T; Zu G; Zhang X; Wang X; Li S; Gong X; Liang Z; Zhao J
Neuropharmacology; 2016 Feb; 101():480-9. PubMed ID: 26525190
[TBL] [Abstract][Full Text] [Related]
22. Wnt/β-catenin Signaling Inhibitors.
Zhang X; Dong N; Hu X
Curr Top Med Chem; 2023; 23(10):880-896. PubMed ID: 36872364
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic Potential of Naturally Occurring Small Molecules to Target the Wnt/β-Catenin Signaling Pathway in Colorectal Cancer.
Oliveira LFS; Predes D; Borges HL; Abreu JG
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053565
[TBL] [Abstract][Full Text] [Related]
24. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
[TBL] [Abstract][Full Text] [Related]
25. Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway.
Vallée A; Lecarpentier Y; Vallée JN
J Exp Clin Cancer Res; 2019 Jul; 38(1):323. PubMed ID: 31331376
[TBL] [Abstract][Full Text] [Related]
26. Identification of quinazoline compounds as novel potent inhibitors of Wnt/β-catenin signaling in colorectal cancer cells.
Li Y; Lu W; Saini SK; Moukha-Chafiq O; Pathak V; Ananthan S
Oncotarget; 2016 Mar; 7(10):11263-70. PubMed ID: 26820295
[TBL] [Abstract][Full Text] [Related]
27. Wnt/beta-catenin pathway: modulating anticancer immune response.
Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
[TBL] [Abstract][Full Text] [Related]
28. Targeting the Wnt/β-catenin signaling pathway in cancer.
Zhang Y; Wang X
J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells.
Leow PC; Tian Q; Ong ZY; Yang Z; Ee PL
Invest New Drugs; 2010 Dec; 28(6):766-82. PubMed ID: 19730790
[TBL] [Abstract][Full Text] [Related]
30. Antitumor Activity of Rutaecarpine in Human Colorectal Cancer Cells by Suppression of Wnt/β-Catenin Signaling.
Byun WS; Bae ES; Kim WK; Lee SK
J Nat Prod; 2022 May; 85(5):1407-1418. PubMed ID: 35544614
[TBL] [Abstract][Full Text] [Related]
31. Discovery of Small-Molecule Inhibitors of the PTK7/β-Catenin Interaction Targeting the Wnt Signaling Pathway in Colorectal Cancer.
Ganier L; Betzi S; Derviaux C; Roche P; Dessaux C; Muller C; Hoffer L; Morelli X; Borg JP
ACS Chem Biol; 2022 May; 17(5):1061-1072. PubMed ID: 35483008
[TBL] [Abstract][Full Text] [Related]
32. Disruption of Wnt/β-catenin Pathway Elevates the Sensitivity of Gastric Cancer Cells to PD-1 Antibody.
Li J; Zhang H; Bei S; Zhang X; Li H; Ye L; Feng L
Curr Mol Pharmacol; 2022; 15(3):557-569. PubMed ID: 34139974
[TBL] [Abstract][Full Text] [Related]
33. Modulation of Wnt/β-catenin signaling pathway by bioactive food components.
Tarapore RS; Siddiqui IA; Mukhtar H
Carcinogenesis; 2012 Mar; 33(3):483-91. PubMed ID: 22198211
[TBL] [Abstract][Full Text] [Related]
34. Discovery of Novel Inhibitor for WNT/β-Catenin Pathway by Tankyrase 1/2 Structure-Based Virtual Screening.
Li B; Liang J; Lu F; Zeng G; Zhang J; Ma Y; Liu P; Wang Q; Zhou Q; Chen L
Molecules; 2020 Apr; 25(7):. PubMed ID: 32268564
[TBL] [Abstract][Full Text] [Related]
35. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
[TBL] [Abstract][Full Text] [Related]
36. Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis.
Li SS; Sun Q; Hua MR; Suo P; Chen JR; Yu XY; Zhao YY
Front Pharmacol; 2021; 12():719880. PubMed ID: 34483931
[TBL] [Abstract][Full Text] [Related]
37. Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF.
Wang H; Zhang H; Chen Y; Wang H; Tian Y; Yi X; Shi Q; Zhao T; Zhang B; Gao T; Guo S; Li C; Guo W
Cells; 2022 Nov; 11(22):. PubMed ID: 36429010
[TBL] [Abstract][Full Text] [Related]
38. Canonical Wnt/Beta-Catenin Signaling Network as Emerging Signaling Cascade for Therapeutic Intervention in Chronic Renal Disease.
Soni H
Curr Drug Targets; 2021; 22(16):1825-1831. PubMed ID: 33593258
[TBL] [Abstract][Full Text] [Related]
39. Effects of natural compounds on Xenopus embryogenesis: a potential read out for functional drug discovery targeting Wnt/β-catenin signaling.
Amado NG; Fonseca BF; Cerqueira DM; Reis AH; Simas AB; Kuster RM; Mendes FA; Abreu JG
Curr Top Med Chem; 2012; 12(19):2103-13. PubMed ID: 23167799
[TBL] [Abstract][Full Text] [Related]
40. Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities.
Huang P; Yan R; Zhang X; Wang L; Ke X; Qu Y
Pharmacol Ther; 2019 Apr; 196():79-90. PubMed ID: 30468742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
